Have a feature idea you'd love to see implemented?
Let us know!
EKSO Ekso Bionics Holdings Inc
Price (delayed)
$0.72
Market cap
$15.84M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.65
Enterprise value
$13.89M
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, Ekso
Highlights
EKSO's EPS is up by 42% year-on-year and by 18% since the previous quarter
The net income has grown by 27% YoY and by 10% from the previous quarter
Ekso Bionics Holdings's equity has increased by 23% QoQ but it has decreased by 2.5% YoY
The gross profit rose by 9% year-on-year but it has declined by 2.6% since the previous quarter
Key stats
What are the main financial stats of EKSO
Market
Valuations
Earnings
Shares outstanding
22M
Market cap
$15.84M
Enterprise value
$13.89M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.89
Price to sales (P/S)
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.79
Revenue
$17.68M
EBIT
-$10.86M
EBITDA
-$8.97M
Free cash flow
-$10.06M
Per share
Balance sheet
Liquidity
EPS
-$0.65
Free cash flow per share
-$0.5
Book value per share
$0.81
Revenue per share
$0.87
TBVPS
$1.19
Total assets
$29.21M
Total liabilities
$14.34M
Debt
$6.35M
Equity
$14.87M
Working capital
$13.56M
Debt to equity
0.43
Current ratio
2.81
Quick ratio
2.03
Net debt/EBITDA
0.22
Margins
Efficiency
Dividend
EBITDA margin
-50.7%
Gross margin
51.8%
Net margin
-63%
Operating margin
-66.1%
Return on assets
-39%
Return on equity
-83.1%
Return on invested capital
-74.8%
Return on capital employed
-50%
Return on sales
-61.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
EKSO stock price
How has the Ekso Bionics Holdings stock price performed over time
Intraday
0.14%
1 week
-5.14%
1 month
-30.1%
1 year
-51.35%
YTD
-71.2%
QTD
-37.93%
Financial performance
How have Ekso Bionics Holdings's revenue and profit performed over time
Revenue
$17.68M
Gross profit
$9.17M
Operating income
-$11.68M
Net income
-$11.13M
Gross margin
51.8%
Net margin
-63%
EKSO's operating margin is up by 30% YoY
The net margin is up by 29% YoY and by 8% QoQ
EKSO's operating income is up by 27% year-on-year and by 2.4% since the previous quarter
The net income has grown by 27% YoY and by 10% from the previous quarter
Growth
What is Ekso Bionics Holdings's growth rate over time
Valuation
What is Ekso Bionics Holdings stock price valuation
P/E
N/A
P/B
0.89
P/S
0.83
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.79
EKSO's EPS is up by 42% year-on-year and by 18% since the previous quarter
EKSO's P/B is 61% below its 5-year quarterly average of 2.3 and 53% below its last 4 quarters average of 1.9
Ekso Bionics Holdings's equity has increased by 23% QoQ but it has decreased by 2.5% YoY
The stock's price to sales (P/S) is 71% less than its 5-year quarterly average of 2.9 and 41% less than its last 4 quarters average of 1.4
Ekso Bionics Holdings's revenue has increased by 4.1% YoY but it has decreased by 2.6% from the previous quarter
Efficiency
How efficient is Ekso Bionics Holdings business performance
The ROIC has grown by 32% YoY and by 10% from the previous quarter
EKSO's return on sales is up by 30% year-on-year and by 8% since the previous quarter
The ROE has grown by 10% from the previous quarter but it has contracted by 9% YoY
The ROA has grown by 9% from the previous quarter and by 8% YoY
Dividends
What is EKSO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for EKSO.
Financial health
How did Ekso Bionics Holdings financials performed over time
Ekso Bionics Holdings's total assets is 104% more than its total liabilities
EKSO's quick ratio is up by 26% QoQ
The current ratio is up by 16% since the previous quarter
The debt is 57% lower than the equity
Ekso Bionics Holdings's equity has increased by 23% QoQ but it has decreased by 2.5% YoY
The debt to equity has declined by 22% since the previous quarter and by 12% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.